Breast Cancer and Immuno Oncology

View overview page

The Breast Cancer Channel on VJOncology is supported by Seagen

The supporters have no influence over the production of the content.

IMpassion031: patient-reported outcomes

Nadia Harbeck • 14 Dec 2020

Next steps in breast cancer: de-escalation & immunotherapy

Roisin Connolly • 11 Dec 2020

Immune oncology in breast cancer: KEYNOTE-086, NCI 10013, & AIPAC

Sangeetha Reddy • 16 Dec 2020

Upcoming advances in breast cancer

Wolfgang Janni • 14 Dec 2020

MARIO-3: eganelisib in TNBC

Erika Hamilton • 15 Dec 2020

Breast cancer trends in 2021 and beyond

Komal Jhaveri • 11 Dec 2020

ASCENT: sacituzumab govitecan biomarker analysis

Sara M. Tolaney • 11 Dec 2020

Exciting updates in biomarkers of response to neoadjuvant chemotherapy

Christos Sotiriou • 27 Nov 2020

Innovative biomarker approaches in breast cancer therapy

Christos Sotiriou • 27 Nov 2020

ASCENT: sacituzumab govitecan shows promise in mTNBC patients

Sara Hurvitz • 30 Nov 2020

SABCS 2020: monarchE, PENELOPE-B, TAILORx & ASCENT

Matteo Lambertini • 9 Dec 2020

What to expect in breast cancer in 2021

Cynthia X. Ma • 3 Dec 2020

PRS-343 in HER2-Positive Solid Tumors: A trial update

Geoffrey Ku • 24 Sep 2020

Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more

Aditya Bardia • 22 Sep 2020

ASCENT trial: sacituzumab govitecan for TNBC

Aditya Bardia • 22 Sep 2020

Critical role of eosinophils during response to ICI blockade

Leonie Voorwerk • 18 Sep 2020

1
2
3
4
Next